MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • 2025 International Congress

    Spatial Metabolic Covariance Networks in PSP: Implications for Symptomatology and their Neural Basis

    B. Wang, W. Luo (Hangzhou, China)

    Objective: This study aimed to apply spatial ICA to 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) data from PSP patients and healthy controls (HCs) to identify…
  • 2025 International Congress

    Asymptomatic GBA1 Mutation Carriers Have Increased Cortical Cholinergic Activity

    M. Matarazzo, J. Mckenzie, S. Dhaliwal, Q. Miao, N. Vafai, R. Alcalay, V. Bruno, A. Lehman, J. Quinn, D. Raymond, D. Safarpour, J. Sarna, R. Saunders-Pullman, S. Sirrs, CP. Zabetian, V. Sossi, AJ. Stoessl (Vancouver, Canada)

    Objective: The objective of this study was to assess cholinergic activity changes in patients with Parkinson’s disease carrying GBA1 variants(GBA-PD) and in non-manifesting carriers(GBA-NMC) using…
  • 2025 International Congress

    Brain Target Engagement and Pharmacokinetic-Enzyme Occupancy (PK-EO) Relationship of FNP-223: A Novel Oral OGA Inhibitor for Progressive Supranuclear Palsy – Phase 1 PET Study

    R. Pokorny, J M. Ryan, E. Rabiner, G. Searle, C. Varona, M. Schneider, C. Wiessner, J F. Stallaert, B. Permanne, A. Quattropani, D. Beher (Lausanne, Switzerland)

    Objective: To determine the brain O-GlcNAcase (OGA) occupancy, following a single oral dose of FNP-223 (formerly ASN90) and to determine PK-EO relationship. Background: Preclinical evidence…
  • 2025 International Congress

    STN-DBS Improves Motor and Cognitive Functions Associated with Increased Occipital Metabolism in PDD Patients

    Q. Zhang, FT. Liu, JJ. Ge, J. Wang, JJ. Wu (Shanghai, China)

    Objective: The study aims to determine whether STN-DBS brings about clinical benefits for Parkinson’s disease dementia (PDD) patients and its association with metabolic change in…
  • 2025 International Congress

    Transcutaneous Afferent Patterned Stimulation: A Non-Invasive Approach to Modulate Brain Metabolism in Essential Tremor

    M. Elgohary, K. Rosenbluth, P. Min, H. Shin, K. Lee (San Mateo, USA)

    Objective: To investigate the mechanism of transcutaneous afferent pattern stimulation (TAPS) using PET imaging to assess brain metabolic changes associated with tremor reduction in individuals…
  • 2025 International Congress

    Seed-based Metabolic Networks and Time Series Variation based on Functional [18F]-FDG PET in Parkinson’s Disease

    M. Ruppert-Junck, V. Heinecke, K. Steidel, L. Rüsing, F. Thiemig, D. Librizzi, T. Schurrat, M. Beckersjürgen, J. Fuchs, H. Müller, M. Luster, L. Timmermann, C. Eggers, D. Pedrosa (Marburg, Germany)

    Objective: To analyse seed-based metabolic networks and time series variation in Parkinson’s disease with and without mild cognitive impairment based on functional PET (fPET) Background:…
  • 2025 International Congress

    The Cholinergic System in Cervical Dystonia – An [18F]-FEOBV PET study

    S. Lagerweij, J. Dalenberg, M. Smit, L. Centen, M. Coenen, M. van Egmond, E. de Vries, D. Peretti, M. Tijssen (Groningen, Netherlands)

    Objective: To investigate presynaptic cholinergic functioning in cervical dystonia (CD) by comparing [18F]-FEOBV binding in patients and controls, as well as exploring correlations with motor…
  • 2025 International Congress

    Metabolic network signature of quantitative motor effects following deep brain stimulation in Parkinson’s disease

    A. Calvano, A. Turan, U. Kleinholdermann, V. Heinecke, K. Steidel, L. Ruesing, F. Thiemig, D. Librizzi, T. Schurrat, M. Beckersjuergen, M. Luster, L. Timmermann, C. Eggers, M. Ruppert-Junck, D. Pedrosa (Marburg, Germany)

    Objective: To integrate [18F]-FDG PET (fPET) and objective motor performance to unravel metabolic networks associated with deep brain stimulation (DBS) outcomes in Parkinson’s disease (PD).…
  • 2024 International Congress

    Combining alpha-synuclein PET and seeded amplification assays to improve the diagnostic accuracy of Multiple System Atrophy of the Parkinsonian subtype (MSA-P)

    D. Rodriguez Gomez, B. Changizi, C. Sandiego, A. Green, A. Kuzkina, J. Alexander, O. Laun, K. Jones, D. Ceku, J. Meehan, S. Perumalla, S. Rai, A. Knorr, V. Hliva, M. Kosco-Vilbois, A. Pfeifer, N. Mendonca, D. Russell, F. Capotosti, V. Khurana (Boston, USA)

    Objective: To determine whether the combination of spatial (PET [18F]ACI-12589) and conformational (skin seed amplification assay; SAA) a-syn data aids the early differential diagnosis of…
  • 2024 International Congress

    Pure Autonomic Failure As a Severe “Body-First Subtype” of Lewy Body Disease: A Multimodal Imaging Study of the Autonomic Nervous System

    C. Skjaerbaek, I. Cani, K. Knudsen, G. Carrozzo, P. Guaraldi, T. Lillethorup, T. Fedorova, A. Terkelsen, P. Cortelli, P. Borghammer (Aarhus, Denmark)

    Objective: Using multi-modal imaging this study aimed to characterize the deterioration of the parasympathetic and sympathetic nervous system in pure autonomic failure (PAF) in comparison…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 40
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley